Ortho Clinical Diagnostics Holdings plc

NASDAQ:OCDX  
17.81
-0.90 (-4.81%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.97B
Current PEN/A
Forward PE 25.44
2yr Forward PE 21.99
See more stats
Estimates Current Quarter
Revenue$481.67 Million
Adjusted EPS$0.14
See more estimates
10-Day MA$18.81
50-Day MA$20.34
200-Day MAN/A
See more pivots

Ortho Clinical Diagnostics Holdings plc Stock, NASDAQ:OCDX

1001 Route 202, Raritan, New Jersey 08869
United States of America
Phone: +1.908.218.8000
Number of Employees: 4500

Description

Ortho Clinical Diagnostics Holdings Plc provides vitro diagnostics services. It offers VITROS XT 7600 Integrated System, VITROS 5600 Integrated System, VITROS 4600 Chemistry System, VITROS?® XT 3400 Chemistry System, VITROS?® 3600 Immunodiagnostic System, VITROS ECiQ Immunodiagnostic System, VITROS Automation Solutions, Informatics Solutions, Assay Menu by Disease State, Microtip Partnership Assays, VITROS HIV Combo Test, Transfusion Medicine, ORTHO VISION Analyzer, ORTHO VISION Max Analyzer, ORTHO CONNECT, ORTHO Workstation, Lab Reliability, Lab Optimization, Training & Education and Lab Support. The company is headquartered in Raritan, NJ.